Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.040
-0.050 (-4.59%)
Nov 21, 2024, 11:32 AM EST - Market open
Cue Biopharma Revenue
Cue Biopharma had revenue of $3.34M in the quarter ending September 30, 2024, with 58.86% growth. This brings the company's revenue in the last twelve months to $9.53M, up 149.53% year-over-year. In the year 2023, Cue Biopharma had annual revenue of $5.49M with 340.96% growth.
Revenue (ttm)
$9.53M
Revenue Growth
+149.53%
P/S Ratio
5.66
Revenue / Employee
$179,849
Employees
53
Market Cap
62.62M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
InterCure | 72.42M |
Celularity | 42.69M |
Cryo-Cell International | 31.84M |
electroCore | 23.33M |
InspireMD | 6.82M |
BeyondSpring | 1.88M |
Monogram Technologies | 365.00K |
CUE News
- 6 days ago - Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 days ago - Cue Biopharma Announces Strategic Organizational Transition - GlobeNewsWire
- 12 days ago - Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting - GlobeNewsWire
- 6 weeks ago - Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire
- 7 weeks ago - Cue Biopharma Announces Pricing of $12.0 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire
- 2 months ago - Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - GlobeNewsWire
- 3 months ago - Cue Biopharma, Inc. (CUE) Q2 2024 Earnings Call Transcript - Seeking Alpha